Pathological gambling (PG) is a signi.cant public health concern associated with high rates of psychiatric comorbidity and mortality. Although research into the biology of PG is still in an early stage, recent advances in our understanding of motivation, reward, and addiction have provided substantial insight into the possible pathophysiology of this disorder. In addition, over the past 5 years, extraordinary progress has been made in the area of clinical research examining treatments for PG. Although PG is a disabling disorder that continues to represent a clinical challenge for the healthcare professional, our current knowledge of pharmacotherapy and psychosocial interventions offers potentially effective treatment options.
KeywordsCocaine Paroxetine Naltrexone Pathological Gambling Gambling Behavior
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Argo T, Black DW: Clinical characteristics. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004:39–53.Google Scholar
- 3.Grant JE, Potenza MN: Pathological gambling and other behavioral addictions. In Clinical Textbook of Addictive Disorders, Third Edition. Edited by Frances RJ, Miller SI, Mack AH. New York: Guildford Press; 2005:303–320.Google Scholar
- 14.Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:03–13. A general review and synthesis of the neurobiology of addiction, with particular focus on the shared neuronal circuitry and neural substrates of choice and reward.CrossRefGoogle Scholar
- 18.Fiorillo CD, Tobler PN, Schultz W: Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003, 299:1898–1902. This study reported a population of midbrain dopaminergic neurons that show discriminatory responses to both the expectancy and magnitude of reward. Dopaminergic neurons were shown to both a phasic response to reward error prediction and a sustained response to the variation in magnitude of the reward. The highest levels of reward uncertainty were shown to correlate with the most robust activation of dopaminergic neurons.PubMedCrossRefGoogle Scholar
- 19.Dreher JC, Kohn P, Berman KF: Neural coding of distinct statistical properties of reward information in humans. Cereb Cortex 2005, In press.Google Scholar
- 25.Breiter HC, Becerra L, Gonzalez RG: Morphine induced reward and pain circuitry activation in drug naive humans [poster abstract]. Paper presented at American Pain Society, Atlanta, GA: 2000.Google Scholar
- 27.Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for involvement of the frontal cortex. Am J Psychiatry 2002, 999:523–528.Google Scholar
- 28.Volkow ND, Wang G-J, Ma Y, et al.: Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003, 23:161–168.Google Scholar
- 31.Shah KR, Potenza MN, Eisen SA: Biological basis for pathological gambling. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC; APPI; 2004.Google Scholar
- 41.Grant JE, Potenza MN, Hollander E, et al.: A multicenter investigation of fixed-dose nalmefene in the treatment of pathological gambling [abstract]. Presented at the National Institute of Mental Health NCDEU 45th Annual Meeting. Boca Raton, FL: June 6–9, 2005.Google Scholar
- 42.Rugle L: The use of olanzapine in the treatment of video poker pathological gamblers [abstract]. Presented at The Comorbidity of Pathological Gambling: A Current Research Synthesis conference. Las Vegas: December 3–5.Google Scholar
- 43.Hodgins DC, Petry NM: Cognitive and behavioral treatments. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004.Google Scholar